First, we aimed to (a) differentiate patients with SNAP from patients with early AD according to PET imaging, (b) compare their neuropsychological-behavioural performances and brain atrophy patterns at baseline, (c) analyse individual tau PET regional binding in order to capture possible “PART” within the SNAP group. The gene discussed is MAPT; the disease is Alzheimer disease.